South Plains Financial’s Charles River Laboratories CRL Stock Holding History

South Plains Financial’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15	Closed	-$2.99K	–	233
2025 Q4	$2.99K	Hold	15	–	–	﹤0.01%	245
2025 Q3	$2.35K	Hold	15	–	–	﹤0.01%	223
2025 Q2	$2.27K	Hold	15	–	–	﹤0.01%	228
2025 Q1	$2.26K	Hold	15	–	–	﹤0.01%	235
2024 Q4	$2.77K	Buy	+15	New	+$2.89K	﹤0.01%	255

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

South Plains Financial's CRL Position: Q1 2026 in Review

South Plains Financial sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 15 shares — an estimated $2.99K sold.

South Plains Financial first reported a position in CRL in Q4 2024 and held it in 5 quarters. The position peaked at $2.99K in Q4 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

South Plains Financial reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
South Plains Financial sold 15 Charles River Laboratories shares in Q1 2026, an estimated $2.99K.
South Plains Financial first reported a position in Charles River Laboratories in Q4 2024 and held it in 5 quarters.
South Plains Financial's Charles River Laboratories position peaked at $2.99K in Q4 2025.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on South Plains Financial's 13F filing for Q1 2026, filed 13 May 2026.